PROPRIUS Canadian Trademark Information

On Wednesday, November 30, 2005, a canadian trademark registration was filed for PROPRIUS by Proprius, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1281338. The current status of this trademark filing is Interruption of proceeding. The PROPRIUS trademark is filed in the description of Medical laboratory services, namely, laboratory testing, evaluation, and research services; medical laboratory services, namely, disease management and pathology services; and medical laboratory services, namely, providing medical laboratory information to health care providers, managed care providers and patients via global computer networks. , Pharmaceutical preparations used for the treatment of inflammatory disorders and diseases, namely, inflammatory bowel disease, Crohn’s Disease, ulcerative colitis, vasculitis, periodontal diseases and rheumatoid arthritis; autoimmune disorders and diseases, namely, Celiac Disease, Diabetes Mellitus Type I (IDDM), Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome, Hashimoto’s Thyroiditis, Graves’ Disease, Rheumatoid Arthritis (RA), Idiopathic Thrombocytopenic Purpura, Sacrolitis and Takayasu’s Arteritis; cardiovascular disorders and diseases; metabolic disorders and diseases, namely, myoadenylate deaminase deficiency, Lesch-Nyhan syndrome, congenital adrenal hyperplasia, Kearns-Sayre syndrome, Zellweger syndrome and Gaucher’s disease, infectious disorders and diseases, namely, Hepatitis B, HIV/AIDS, tuberculosis, meningitis, measles, Chaga’s disease, Arachnoiditis, Discitis and influenza, musculoskeletal disorders and diseases, namely, osteoporosis, back pain, osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, degenerative disc disease, gout and fibromyalgia, immune modulation and management of side effects, namely, pharmaceutical preparations for improving and restoring various specific areas of the immune system, pharmaceutical preparations for use in treating cancer, namely, multiple myeloma, leukemia, lymphoma, melanoma, colon cancer, pharynx cancer, lung cancer, prostate cancer, breast cancer; diagnostic preparations for clinical or medical laboratory use; and diagnostic reagents for clinical or medical laboratory use. .